Selina Epp
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Nonregistration, Discontinuation, and Nonpublication of Randomized Trials: A Systematic Review.
Journal: JAMA network open
Published: September 03, 2025
Metaresearch on patient-reported outcomes in trial protocols and results publications suggested large outcome reporting bias.
Journal: Journal of clinical epidemiology
Published: October 27, 2024
Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022.
Journal: Swiss medical weekly
Published: April 05, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines.
Journal: Cell reports. Medicine
Published: February 26, 2024
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
Journal: mBio
Published: January 25, 2024
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1.
Journal: AIDS (London, England)
Published: October 13, 2023
Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study.
Journal: The Journal of infectious diseases
Published: July 20, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).
Journal: Open forum infectious diseases
Published: July 06, 2023
Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity.
Journal: The Journal of infectious diseases
Published: February 15, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).
Journal: Open forum infectious diseases
Published: November 14, 2022
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation.
Journal: British journal of haematology
Published: September 11, 2022
Last Updated: 09/26/2026